SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-23-003928
Filing Date
2023-03-17
Accepted
2023-03-17 16:15:49
Documents
12
Period of Report
2023-03-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K maia-8k_20230313.htm   iXBRL 8-K 42892
  Complete submission text file 0001564590-23-003928.txt   175671

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA maia-20230313.xsd EX-101.SCH 5585
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE maia-20230313_lab.xml EX-101.LAB 20222
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE maia-20230313_pre.xml EX-101.PRE 11988
6 EXTRACTED XBRL INSTANCE DOCUMENT maia-8k_20230313_htm.xml XML 3699
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 23742776
SIC: 2834 Pharmaceutical Preparations